Almut G. Winterstein

Geciteerd door

	Alles	Sinds 2020
Citaties	13029	6382
h-index	43	32
i10-index	158	119

1500

750

375

1125

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202550 83 115 143 165 214 238 295 391 428 538 566 632 747 897 877 1056 1178 1271 1232 1438 192

Openbare toegang

Alles bekijken

79 artikelen

18 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Joshua D. BrownAssociate Professor, Center for Drug Evaluation & Safety, Pharmaceutical Outcomes & PolicyGeverifieerd e-mailadres voor ufl.edu
Yu-Jung "Jenny" WeiThe Ohio State UniversityGeverifieerd e-mailadres voor osu.edu
Tobias GerhardProfessor of Pharmacy and Epidemiology, Rutgers UniversityGeverifieerd e-mailadres voor ifh.rutgers.edu
Richard SegalProfessor and Associate DeanGeverifieerd e-mailadres voor ufl.edu
Patrick AntonelliProfessor & Chair, Department of Otolaryngology, University of FloridaGeverifieerd e-mailadres voor ufl.edu
Amir Sarayani PhD, PharmD, MPHJohnson & Johnson | University of Florida, College of PharmacyGeverifieerd e-mailadres voor its.jnj.com
Yanmin ZhuBrigham and Women’s Hospital and Harvard Medical SchoolGeverifieerd e-mailadres voor bwh.harvard.edu
Regina BussingProfessor of Psychiatry, University of FloridaGeverifieerd e-mailadres voor ufl.edu
Xinyue LiuMerck & Co. IncGeverifieerd e-mailadres voor merck.com
Babette BrumbackProfessor of Biostatistics, University of FloridaGeverifieerd e-mailadres voor ufl.edu
Juan M. Hincapie-CastilloDepartment of Epidemiology, University of North Carolina at Chapel HillGeverifieerd e-mailadres voor unc.edu
Julie A JohnsonThe Ohio State UniversityGeverifieerd e-mailadres voor osumc.edu
Gloria LiporiUniversity of FloridaGeverifieerd e-mailadres voor ufl.edu
Michael DanielsDepartment of Statistics, University of FloridaGeverifieerd e-mailadres voor stat.ufl.edu
Yan LiFood and Drug Administration, University of FloridaGeverifieerd e-mailadres voor fda.hhs.gov
Haesuk ParkPharmaceutical Outcomes and Policy, University of Florida College of PharmacyGeverifieerd e-mailadres voor cop.ufl.edu
Joseph DelaneyResearch associate professor, University of WashingtonGeverifieerd e-mailadres voor uw.edu
Yoonyoung ChoiMerck Research LabGeverifieerd e-mailadres voor merck.com
Rhonda M Cooper-DeHoffUniversity of FloridaGeverifieerd e-mailadres voor cop.ufl.edu
Chris Delcher, PhDUniversity of Kentucky, Institute for Pharmaceutical Outcomes & PolicyGeverifieerd e-mailadres voor uky.edu

Volgen

Almut G. Winterstein

Professor for Pharmaceutical Outcomes and Policy, University of Florida

Geverifieerd e-mailadres voor ufl.edu - Homepage

Pharmacoepidemiology Patient Safety Research


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Validity and reliability of measurement instruments used in research CL Kimberlin, AG Winterstein American journal of health-system pharmacy 65 (23), 2276-2284, 2008	3507	2008
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection Committee on Infectious Diseases and Bronchiolitis Guidelines Committee Pediatrics 134 (2), e620-e638, 2014	923*	2014
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care LA Thomsen, AG Winterstein, B S⊘ ndergaard, LS Haugb⊘ lle, ... Annals of Pharmacotherapy 41 (9), 1411-1426, 2007	549	2007
Preventable drug-related hospital admissions AG Winterstein, BC Sauer, CD Hepler, C Poole Annals of Pharmacotherapy 36 (7-8), 1238-1248, 2002	469	2002
Nature of preventable adverse drug events in hospitals: a literature review P Kanjanarat, AG Winterstein, TE Johns, RC Hatton, R Gonzalez-Rothi, ... American journal of health-system pharmacy 60 (17), 1750-1759, 2003	391	2003
Drug—drug interactions in the elderly IK Björkman, J Fastbom, IK Schmidt, CB Bernsten, ... Annals of Pharmacotherapy 36 (11), 1675-1681, 2002	347	2002
Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use JD Brown, AG Winterstein Journal of clinical medicine 8 (7), 989, 2019	330	2019
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018	289	2018
Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries C Bernsten, I Björkman, M Caramona, G Crealey, B Frøkjær, ... Drugs & aging 18, 63-77, 2001	269	2001
Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports AG Winterstein, RC Hatton, R Gonzalez-Rothi, TE Johns, R Segal American journal of health-system pharmacy 59 (18), 1742-1749, 2002	210	2002
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder AG Winterstein, T Gerhard, J Shuster, M Johnson, JM Zito, A Saidi Pediatrics 120 (6), e1494-e1501, 2007	178	2007
Nature and causes of clinically significant medication errors in a tertiary care hospital AG Winterstein, TE Johns, EI Rosenberg, RC Hatton, R Gonzalez-Rothi, ... American Journal of Health-System Pharmacy 61 (18), 1908-1916, 2004	174	2004
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion DJ Guervil, AF Rosenberg, AG Winterstein, NS Harris, TE Johns, ... Annals of Pharmacotherapy 45 (7-8), 861-868, 2011	168	2011
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database AG Winterstein, T Gerhard, J Shuster, J Zito, M Johnson, H Liu, A Saidi Annals of Pharmacotherapy 42 (1), 24-31, 2008	149	2008
Causes of hyperglycemia and hypoglycemia in adult inpatients WD Smith, AG Winterstein, T Johns, E Rosenberg, BC Sauer American Journal of Health-System Pharmacy 62 (7), 714-719, 2005	144	2005
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications C Hampp, TL Kauf, AS Saidi, AG Winterstein Archives of pediatrics & adolescent medicine 165 (6), 498-505, 2011	116	2011
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder M Olfson, C Huang, T Gerhard, AG Winterstein, S Crystal, PD Allison, ... Journal of the American Academy of Child & Adolescent Psychiatry 51 (2), 147-156, 2012	103	2012
Ambulatory care: efficacy and safety of oral phenylephrine: systematic review and Meta-analysis RC Hatton, AG Winterstein, RP McKelvey, J Shuster, L Hendeles Annals of Pharmacotherapy 41 (3), 381-390, 2007	101	2007
The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ... Clinical and translational science 10 (3), 143, 2017	99	2017
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study AG Winterstein, T Gerhard, P Kubilis, A Saidi, S Linden, S Crystal, J Zito, ... Bmj 345, 2012	98	2012

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs